Impact of COVID-19 infection among myasthenia gravis patients- a Cerner Real-World Data(TM) study

BACKGROUND: Myasthenia gravis (MG) is an auto-immune disease, and the mainstay of therapy is immunomodulation. Such patients are at high risk of acquiring any infections. Hence, we sought to determine the impact of the current global pandemic COVID-19 infection in MG patients. METHODS: For our study...

Descripción completa

Detalles Bibliográficos
Autores principales: Digala, Lakshmi Prasanna, Prasanna, Shivika, Rao, Praveen, Qureshi, Adnan I., Govindarajan, Raghav
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8792518/
https://www.ncbi.nlm.nih.gov/pubmed/35086486
http://dx.doi.org/10.1186/s12883-022-02564-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8792518/
https://www.ncbi.nlm.nih.gov/pubmed/35086486
http://dx.doi.org/10.1186/s12883-022-02564-x

Ejemplares similares